your market intelligence analyst
Search Results
237 results
Your search is now limited to «AstraZeneca» expert search. 07/19/2019 01:34
According to a newly published report by, “Worldwide Myocardial Infarction Drugs Market: Information About Key Drivers, Restraints, And Opportunities 2019-2028“. The prime objective of the report is to deliver a Ten-year (2019-2028) market forecast. The latest study focusing on myocardial infarction drugs market with topmost companies, to determine, define and analyses the sales size, value, market share, market competition landscape, and recent development. It helps to decide a corpor…
More from
Pharmafile 07/17/2019 05:13
AstraZeneca has revealed plans to use only electric vehicles by 2030.
More from Pharmafile:
AstraZeneca’s oncology immunotherapy Imfinzi (durvalumab) has been granted orphan drug designation (ODD) for the treatment of small cell lung cancer (SCLC.
More from Pharmaceutical Business Review:
BioPharma Dive 07/15/2019 11:51
Results from the PRIMA study show GSK's Zejula improved progression free survival when used as a frontline maintenance treatment for ovarian cancer.
More from BioPharma Dive:
FiercePharmaManufacturing 07/15/2019 10:42
AstraZeneca's Farxiga follows rival Zynquista to FDA rejection in Type 1 diabetes.
More from FiercePharmaManufacturing:
ENDPOINTS 07/15/2019 07:01
The FDA has just fired its latest salvo at the SGLT class of diabetes drugs, blowing up some commercial opportunity at AstraZeneca as part of the collateral damage.
More from ENDPOINTS: 07/15/2019 02:31
RPT-AstraZeneca's Farxiga fails to get FDA approval for Type-1 diabetes.
More from
PR Newswire 07/09/2019 09:00
This project is made possible by support from AstraZeneca and Merck.
More from PR Newswire:
pharmaphorum 07/05/2019 06:51
AstraZeneca is appealing against NICE’s decision not to recommend funding for its lung cancer drug Tagrisso (osimertinib) in untreated patients with epidermal growth factor receptor (EGFR) mutations.
More from pharmaphorum:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications